Videos
Driving Change: What the PCC Working Group Has Learned and What’s Next
08/13/2025
The Predictable Cost of Care Working Group (the PCC) is a multi-organizational effort comprised of pharmaceutical and biotech manufacturers, pathway vendor organizations, community practices, IDNs, and payers. The purpose of the PCC is to inform pathway developers and practices about a greater span of costs than simply drug costs; provide relevant context in competitive situations; and identify areas for quality improvement, efficiency. In this discussion, Rhonda Henschel, SVP at US Oncology, shares how treatment pathways and the Predictable Cost of Care model support value-based care by enabling scalable, disease-agnostic cost frameworks and informing pathway development through consistent, data-driven decision-making.